
Outro is building the first integrated deprescribing network to help people safely stop unnecessary medications-starting with antidepressants. Co-founded by health tech entrepreneur Brandon Goode and Dr. Mark Horowitz, the world-leading researcher on the practice of deprescribing, Outro's flagship Taper Management program is currently available in 14 states. The company is headquartered in New York.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/09/26 | $7,000,000 | Pre-Seed |
Actions Capital Brock Recovery Group Cake Ventures Hannah Grey LAUNCH Listen Ventures Pave Health Ventures SemperVirens | undisclosed |